Shanghai, China

Juan Su

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Juan Su in Myocarditis and Multiple Sclerosis Treatment

Introduction

Juan Su is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the treatment of myocarditis and multiple sclerosis. With a total of four patents to his name, his work focuses on the development of innovative therapeutic compounds.

Latest Patents

Juan Su's latest patents include "Line leaf inula flower lactone A and methods for preparing and using the same for treating myocarditis." This compound demonstrates positive therapeutic activity against the Coxsackie virus and shows a significant dose-dependent correlation. The line leafflower lactone A has been effective in preventing disease in mouse models of experimental autoimmune myocarditis when administered at a dose of 20 mg/kg/d. When the dosage is increased to 100 mg/kg/d, it exhibits a positive therapeutic effect on experimental autoimmune myocarditis. The compound is utilized as the sole active ingredient in various pharmaceutical forms, including tablets, capsules, and injections.

Another notable patent is "Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis." This compound has shown therapeutic effects on the experimental autoimmune encephalomyelitis (EAE) model, indicating its potential for developing drugs to treat multiple sclerosis. Similar to his myocarditis patent, the pharmaceutical composition may be available in various forms, highlighting its versatility and clinical application potential.

Career Highlights

Throughout his career, Juan Su has worked with reputable organizations, including Shanxi Zhendong Pilot Biological Science and Technology Co., Ltd. and the Second Military Medical University. His experience in these institutions has contributed to his expertise in developing innovative treatments for serious medical conditions.

Collaborations

Juan Su has collaborated with notable colleagues, including Weidong Zhang and Lei Shan. Their combined efforts have further advanced the research and development of therapeutic solutions in the medical field.

Conclusion

Juan Su's innovative work in the development of line leafflower lactone A represents a significant advancement in the treatment of myocarditis and multiple sclerosis. His contributions to medical science continue to pave the way for new therapeutic options that hold great promise for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…